Efficiency of a Randomized Confirmatory Basket Trial Design Constrained to Control the False Positive Rate by Indication | bioRxiv
Basket Trials for Cancer Treatments – Cofactor Genomics
Master protocol trials in oncology: Review and new trial designs - ScienceDirect
Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples. | Semantic Scholar
Frontiers | Basket Trials for Intractable Cancer
Basket Trials: Features, Examples, and Challenges
Umbrella and basket trials in oncology: ethical challenges | BMC Medical Ethics | Full Text
Key Design Thoughts for Basket Trials and Umbrella Trials by Jay Park
Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols | Trials | Full Text
Basket Trials for Cancer Treatments – Cofactor Genomics
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both | NEJM
Comparing the Efficacy of Cancer Therapies between Subgroups in Basket Trials - ScienceDirect
Frontiers | Basket Trials for Intractable Cancer
Adaptive Designs for Clinical Trials | Precision for Medicine
Adaptive Designs for Clinical Trials | Precision for Medicine
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response | European Respiratory Society
Life | Free Full-Text | Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials
Basket Trials: Features, Examples, and Challenges
An overview of precision oncology basket and umbrella trials for clinicians - Park - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
An overview of precision oncology basket and umbrella trials for clinicians - Park - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Rethinking clinical trials for next-generation cancer drugs
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology
